 | Up a level |
2018
Cheung, K. L., Evers, S. M. A. A., De Vries, H., Levy, P., Pokhrel, S., Jones, T., Danner, M., Wentlandt, J., Knufinke, L., Mayer, S. and Hiligsmann, M. (2018). Most important barriers and facilitators of HTA usage in decision-making in Europe. Expert Rev. Pharmacoecon. Outcomes Res., 18 (3). S. 297 - 305. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-8379
2017
Gutknecht, M., Schaarschmidt, M. L., Danner, M. and Augustin, M. (2017). Which Therapeutic Goals do Patients prefer with Psoriasis? Results of a Method Comparison. J. Dtsch. Dermatol. Ges., 15. S. 126 - 128. HOBOKEN: WILEY. ISSN 1610-0387
2016
Danner, M., Mueller, D., Schmutzler, R., Rhiem, K., Engel, C., Stollenwerk, B., Stock, S. and Wassermann, K. (2016). ECONOMIC MODELING OF RISK-ADAPTED SCREEN-AND-TREAT STRATEGIES IN WOMEN AT HIGH-RISK FOR BREAST OR OVARIAN CANCER. Value Health, 19 (7). S. A737 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733
Gutknecht, M., Danner, M. and Augustin, M. (2016). USING ANALYTIC HIERARCHY PROCESS TO WEIGHT PATIENT-RELEVANT OUTCOMES IN THE TREATMENT OF PSORIASIS FOR CALCULATING THE PATIENT BENEFIT INDEX. Value Health, 19 (7). S. A389 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733
Vennedey, V., Danner, M., Civello, D., Schwalm, A., Seidl, A. and Hiligsmann, M. (2016). PATIENTS' PREFERENCES FOR CHARACTERISTICS OF PERIODONTAL DISEASE AND ITS' TREAT MENT: A DISCRETE CHOICE EXPERIMENT. Value Health, 19 (7). S. A352 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733
2014
Stock, S. and Danner, M. (2014). Does the elicitation of stakeholder attitudes and preferences add valuable information to small-area analyses? A health policy perspective. Bundesgesundheitsblatt-Gesund., 57 (2). S. 188 - 197. NEW YORK: SPRINGER. ISSN 1437-1588